{"result": {"id": "8c44190e-8093-4165-aafe-664e8a98ce09", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>HYPERTENSION<|>organization<|>Hypertension is a chronic medical condition characterized by elevated blood pressure, which is both a cause and consequence of CKD.\")\n##\n(\"entity\"<|>DIABETES<|>organization<|>Diabetes is a chronic condition that affects blood sugar levels and is often comorbid with CKD.\")\n##\n(\"entity\"<|>CARDIOVASCULAR DISEASE<|>organization<|>Cardiovascular disease refers to conditions affecting the heart and blood vessels, which are common complications in CKD patients.\")\n##\n(\"relationship\"<|>HYPERTENSION<|>CKD<|>Hypertension and CKD are mutually causative and exacerbating conditions.<|>9)\n##\n(\"relationship\"<|>DIABETES<|>CKD<|>Diabetes is a major risk factor for the development and progression of CKD.<|>8)\n##\n(\"relationship\"<|>CARDIOVASCULAR DISEASE<|>CKD<|>CKD increases the risk of cardiovascular disease and mortality.<|>8)\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751558749, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 238, "prompt_tokens": 2903, "total_tokens": 3141, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 2816}, "prompt_cache_hit_tokens": 2816, "prompt_cache_miss_tokens": 87}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: �张压 ≥80mmHg时启动降压药物治疗 , 血  压控制目标为<130/80mmHg( Ⅱa,B) 。\n　　　·无论是否合并糖尿病 ,有蛋白尿的 CKD患者 初始降压治疗应包括一种 ACEI或 ARB( Ⅰ ,B) 。\n　　　· 糖尿病和非糖尿病肾病的 CKD 患者 , 如果 eGFR≥20mL/(min·1.73m2) ,建议使用SGLT2i(Ⅰ,A)。\n\n\n\n\n　　　高血压和 CKD互为病因和加重因素 。除神经-体 液机制外 ,容量及血管硬化在 CKD患者高血压的发 病中也发挥了重要作用 。我国 CKD患者高血压的患 病率为 62.0%~71.2% ,随着肾功能下降高血压患病 率不断升高[585-587] 。 同时 ,CKD患者的高血压还常合 并血压节律异常 ,表现为夜间血压升高 ,并与患者不良 预后相关[435,588] 。 因此 ,除了常规诊室血压的监测 ,还 应重视诊室外血压 ,如动态血压的监测评估。\n　8.6.1   降压目标    蛋白尿是 CKD患者肾功能减退  及发生心血管疾病/死亡的危险因素 。 因此 , CKD患  者的药物降压启动时机及降压目标依据有无蛋白尿而  不同 。无蛋白尿(正常/轻微增高) 和有蛋白尿(中度增  高和重 度 增 高) 的 评 定 方 法 见 表 26。 尿 白 蛋 白<  30mg/24h(UACR<30 mg/g) 的 CKD 患者 , 收缩  压≥140mmHg和/或舒张压 ≥90mmHg时启动降  压药物治疗 ,血压控制目标为<140/90mmHg;尿白  蛋白>30mg/24h(UACR>30mg/g) 的 CKD患者 ,  收缩压≥130mmHg和/或舒张压 ≥80mmHg时启  动降压药物治疗 ,血压控制目标为<130/80mmHg。 如能耐受 ,可考虑将血压进一步降低。\n表 26  不同尿蛋白评定方法对照表\n\n测量指标\t单位\t正常/轻微 增高\t中度增高\t重度增高\n白蛋白排泌率(AER)\tmg/24h\t<30\t30~300\t>300\n蛋白排泌率(PER)\tmg/24h\t<150\t150~500\t>500\n白蛋白肌酐比(ACR)\tmg/mmol\t<3\t3~30\t>30\n\tmg/g\t<30\t30~300\t>300\n蛋白肌酐比值(PCR)\tmg/mmol\t<15\t15~50\t>50\n\tmg/g\t<150\t150~500\t>500\n\n　　　老年 CKD合并高血压患者的降压治疗研究证据  有限 。建议制定个体化降压方案 ,在可耐受的前提下 ,  逐步 调 整 , 使 血 压 平 稳 达 标 。对 65~ 79岁 的 老 年  CKD患者 ,可遵循上述降压启动时机及血压控制 目  标 。对高 龄 老 年(≥80岁) CKD 患 者 , 血 压 ≥150/ 90mmHg时 �\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>CKD<|>organization<|>Chronic Kidney Disease (CKD) is a condition characterized by kidney damage and decreased kidney function, often associated with hypertension and other complications.\")\n##\n(\"entity\"<|>ACEI<|>organization<|>Angiotensin-Converting Enzyme Inhibitors (ACEIs) are a class of medications used to treat high blood pressure and heart failure, often recommended for CKD patients with proteinuria.\")\n##\n(\"entity\"<|>ARB<|>organization<|>Angiotensin II Receptor Blockers (ARBs) are a class of medications used to treat high blood pressure and heart failure, often recommended for CKD patients with proteinuria.\")\n##\n(\"entity\"<|>SGLT2i<|>organization<|>Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2is) are a class of medications used to treat type 2 diabetes and are recommended for CKD patients with eGFR ≥20mL/(min·1.73m2).\")\n##\n(\"relationship\"<|>CKD<|>ACEI<|>ACEIs are recommended as initial降压治疗 for CKD patients with proteinuria.<|>8)\n##\n(\"relationship\"<|>CKD<|>ARB<|>ARBs are recommended as initial降压治疗 for CKD patients with proteinuria.<|>8)\n##\n(\"relationship\"<|>CKD<|>SGLT2i<|>SGLT2is are recommended for CKD patients with eGFR ≥20mL/(min·1.73m2).<|>8)\n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_bdb44b01467a0f068f2e37b10c6fc53549e66fba8889b37294939f5badabd683_v2"}